132 related articles for article (PubMed ID: 6852977)
1. Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues.
Allan PM; Garson JA; Harper EI; Asser U; Coakham HB; Brownell B; Kemshead JT
Int J Cancer; 1983 May; 31(5):591-8. PubMed ID: 6852977
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody UJ 127:11 detects a 220,000-240,000 kdal. glycoprotein present on a sub-set of neuroectodermally derived cells.
Kemshead JT; Fritschy J; Garson JA; Allan P; Coakham H; Brown S; Asser U
Int J Cancer; 1983 Feb; 31(2):187-95. PubMed ID: 6826247
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody UJ13A recognizes the neural cell adhesion molecule (NCAM).
Patel K; Rossell RJ; Bourne S; Moore SE; Walsh FS; Kemshead JT
Int J Cancer; 1989 Dec; 44(6):1062-8. PubMed ID: 2558078
[TBL] [Abstract][Full Text] [Related]
4. Human fetal brain antigen expression common to tumors of neuroectodermal tissue origin.
Wikstrand CJ; Bourdon MA; Pegram CN; Bigner DD
J Neuroimmunol; 1982 Aug; 3(1):43-62. PubMed ID: 6284796
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies M340 and UJ181.4 recognize antigens associated with primitive neuroectodermal tumours/tissues.
Bourne S; Pemberton L; Moseley R; Lashford LS; Coakham HB; Kemshead JT
Hybridoma; 1989 Aug; 8(4):415-26. PubMed ID: 2550359
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody (ERIC-1), raised against retinoblastoma, that recognizes the neural cell adhesion molecule (NCAM) expressed on brain and tumours arising from the neuroectoderm.
Bourne SP; Patel K; Walsh F; Popham CJ; Coakham HB; Kemshead JT
J Neurooncol; 1991 Apr; 10(2):111-9. PubMed ID: 1895159
[No Abstract] [Full Text] [Related]
7. Expression of human fetal brain antigens by human tumors of neuroectodermal origin as defined by monoclonal antibodies.
Wikstrand CJ; Bigner DD
Cancer Res; 1982 Jan; 42(1):267-75. PubMed ID: 6274512
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody to a cytoskeletal protein selectively recognizing malignant neuroectodermal tumors.
Chakrabarti SK; Sil M; Poddar R; Sarkar PK
Hybridoma; 1994 Dec; 13(6):491-7. PubMed ID: 7737673
[TBL] [Abstract][Full Text] [Related]
9. Common neuroectodermal antigens on human melanoma, neuroblastoma, retinoblastoma, glioblastoma and fetal brain revealed by hybridoma antibodies raised against melanoma cells.
Liao SK; Clarke BJ; Kwong PC; Brickenden A; Gallic BL; Dent PB
Eur J Immunol; 1981 Jun; 11(6):450-4. PubMed ID: 7262181
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of neuroblastoma using radiolabeled monoclonal antibody UJ13A.
Goldman A; Vivian G; Gordon I; Pritchard J; Kemshead J
J Pediatr; 1984 Aug; 105(2):252-6. PubMed ID: 6747756
[TBL] [Abstract][Full Text] [Related]
11. [Preparing monoclonal antibodies to thyroxine].
Danilova ND; Krupina NV; Mertts MV; Vasilov RG
Bioorg Khim; 1993 Jul; 19(7):704-12. PubMed ID: 8373450
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.
Modak S; Kramer K; Gultekin SH; Guo HF; Cheung NK
Cancer Res; 2001 May; 61(10):4048-54. PubMed ID: 11358824
[TBL] [Abstract][Full Text] [Related]
13. Mouse monoclonal antibody to embryonic antigen: development, cross-reactivity with rodent and human tumors, and preliminary polypeptide characterization.
Payne WJ; Coggin JH
J Natl Cancer Inst; 1985 Sep; 75(3):527-44. PubMed ID: 2411994
[TBL] [Abstract][Full Text] [Related]
14. Immunohistological diagnosis of central nervous system tumours using a monoclonal antibody panel.
Coakham HB; Garson JA; Allan PM; Harper EI; Brownell B; Kemshead JT; Lane EB
J Clin Pathol; 1985 Feb; 38(2):165-73. PubMed ID: 3881481
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody detecting an antigen shared by neural and granulocytic cells.
Kemshead JT; Bicknell D; Greaves MF
Pediatr Res; 1981 Sep; 15(9):1282-6. PubMed ID: 7290779
[TBL] [Abstract][Full Text] [Related]
16. HNK-1 antibody detects an antigen expressed on neuroectodermal cells.
Lipinski M; Braham K; Caillaud JM; Carlu C; Tursz T
J Exp Med; 1983 Nov; 158(5):1775-80. PubMed ID: 6195296
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies that demonstrate specificity for several types of human lung cancer.
Cuttitta F; Rosen S; Gazdar AF; Minna JD
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4591-5. PubMed ID: 6270685
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical detection of tumours of neuroectodermal origin.
Carey PJ; Malcolm AJ; Pearson AD; Kemshead JT; Reid MM
J Clin Pathol; 1988 May; 41(5):586-9. PubMed ID: 3290267
[TBL] [Abstract][Full Text] [Related]
19. Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumors.
de Muralt B; de Tribolet N; Diserens AC; Carrel S; Mach JP
Anticancer Res; 1983; 3(1):1-6. PubMed ID: 6830147
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody (FMG25) that can differentiate neuroblastoma from other small round-cell tumours of childhood.
Gibson FM; Kemshead JT
Int J Cancer; 1987 May; 39(5):554-9. PubMed ID: 3494688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
